Enliven Therapeutics
ELVN
#5280
Rank
A$1.87 B
Marketcap
$38.33
Share price
-0.57%
Change (1 day)
119.49%
Change (1 year)

Enliven Therapeutics (ELVN) - Total debt

Total debt on the balance sheet as of September 2024 : A$0.13 Million

According to Enliven Therapeutics's latest financial reports the company's total debt is A$0.13 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

Enliven Therapeutics - Total debt on balance sheet (from 2021 to 2024)

Total debt by year

Year Total debt Change
2023-12-31A$0.49 M3.59%
2022-12-31A$0.47 M116.42%
2021-12-31A$0.21 M60.61%
2020-12-31A$0.13 M